HomeHealthcare & Life SciencesBiotechnology Stargardts Treatment Market

LATAM Stargardts Treatment Market Size & Outlook, 2026-2034


LATAM Stargardts Treatment Market Insights

  • According to Reed Intelligence analysis, the LATAM Stargardts Treatment Market size stood at USD 308.87 Million in 2025 and is forecasted to reach USD 843.08 Million by 2034.
  • The market is projected to grow at a CAGR of 11.75% between 2026 and 2034.
  • By segment, Gene Therapy was the leading Treatment Type in terms of market size in 2025.
  • Gene Therapy is expected to be the most lucrative Treatment Type segment, exhibiting the fastest growth throughout the forecast period.

Other Key Findings


  • LATAM held 7.8% share of the global Stargardts Treatment Market size in 2025.
  • United States is expected to remain the largest contributor to the global market size by 2034.
  • By 2034, Brazil is anticipated to record the highest growth in LATAM, with the market size expected to reach USD 330.65 Million.

Report Summary

Report Scope Details
Base Year for Study 2025
Study Period 2022-2034
Historical Period 2022-2024
Forecast Period 2026-2034
Market Size In 2025 USD 308.87 Million
Market Size In 2034 USD 843.08 Million
Largest segment Gene Therapy
Units Revenue in USD Million
CAGR 11.75% (2026-2034)
Segmnetation Covered
LATAM
  1. Brazil
  2. Mexico
  3. Argentina
  4. Colombia
  5. Chile
Treatment Type
  1. Gene Therapy
  2. Stem Cell Therapy
  3. Pharmacological Therapy
  4. Nutritional and Supportive Therapy
Disease Stage
  1. Early Stage
  2. Intermediate Stage
  3. Advanced Stage
End-Use
  1. Hospitals and Ophthalmology Clinics
  2. Research Institutes
  3. Specialty Eye Centers
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports